Reali Kenneth Michael's Form 4 filing
Bioventus Inc. (BVS) · filed Mar 16, 2023
- Accession no.
- 0000899243-23-008792
- Filed
- Mar 16, 2023
- Trade date
- Mar 14, 2022-Mar 15, 2023
- Filing delay
- 367 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $13.6K. It was filed 367 days after the trade, past the 2-business-day deadline.
This filing was later replaced by the amendment 0001578563-23-000024 (Apr 21, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reali Kenneth MichaelCIK 0001480801 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2022 | Class A Common Stock | AGrant or awardAcquired | +114,882 | $0.00 | $0 | 114,882 | Direct | |
| Mar 14, 2023 | Class A Common Stock | MOption exerciseDisposed | −28,721 | $0.00 | $0 | 86,161 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.37 to $1.43, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Referenced by the price of 1 transaction in Table I.